TAK PAUL PETER (President & CEO) received a stock award from CANDEL THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/26/2025ACC: 0000950170-25-090198
DirectorOfficer· President & CEO
Since Jul 2021
+42.83K
Net shares
Net buyer
$200.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
42.83K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+42.83K
Price / share
$4.67
Trade value
$200K
% of position
19.0%
6/25/2025
225.74K→268.57K
Total
Net shares
+42.83K
Net value
$200K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2025 | A · Award | +42.83K | $4.67 | $200K | 19.0% | 225.74K | 268.57K |
| Total | +42.83K | $200K | ||||||
Derivative Transactions0
No derivative transactions reported